Emily He

Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study

Jie‐Bin Lew, David John, Xiang-Ming Xu et al. · The Lancet Public Health · 2017 · 167 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia

Jie‐Bin Lew, David John, Finlay Macrae et al. · International Journal of Cancer · 2018 · 67 citations · Full text

Medicine, Pharmacoeconomics, Preventive Medicine +17

Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress

Zhaohui Pei, Qinqin Deng, Sara A. Babcock et al. · Toxicology Letters · 2017 · 65 citations

Life Sciences, Cardiology, Cell Biology +15

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia

Jie‐Bin Lew, David John, Finlay Macrae et al. · Cancer Epidemiology Biomarkers & Prevention · 2018 · 55 citations

Medicine, Oncology, Preventive Medicine +17

Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort

Emily He, Jie‐Bin Lew, Sam Egger et al. · Preventive Medicine · 2017 · 51 citations

Medicine, Oncology, Preventive Medicine +14